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Implication of NOTCH1 gene in susceptibility to anxiety
and depression among sexual abuse victims
IM Steine1,15, T Zayats2, C Stansberg3,4, S Pallesen5,6, J Mrdalj6,7, B Håvik8, J Soulé7,9, J Haavik2,10, AM Milde7,11, S Skrede8, R Murison7,
J Krystal12,13 and J Grønli7,14
Sexual abuse contributes to the development of multiple forms of psychopathology, including anxiety and depression, but the
extent to which genetics contributes to these disorders among sexual abuse victims remains unclear. In this translational study, we
first examined gene expression in the brains of rodents exposed to different early-life conditions (long, brief or no maternal
separation). Hypothesizing that genes revealing changes in expression may have relevance for psychiatric symptoms later in life, we
examined possible association of those genes with symptoms of anxiety and depression in a human sample of sexual abuse
victims. Changes in rodent brain gene expression were evaluated by means of correspondence and significance analyses of
microarrays by comparing brains of rodents exposed to different early-life conditions. Tag single-nucleotide polymorphisms (SNPs)
of resulting candidate genes were genotyped and tested for their association with symptoms of anxiety and depression (Hospital
Anxiety and Depression Scale) in a sample of 361 sexual abuse victims, using multinomial logistic regression. False discovery rate
was applied to account for multiple testing in the genetic association study, with q-value of 0.05 accepted as significant. We
identified four genes showing differential expression among animals subjected to different early-life conditions as well as having
potential relevance to neural development or disorders: Notch1, Gabrr1, Plk5 and Zfp644. In the human sample, significant
associations were observed for two NOTCH1 tag SNPs: rs11145770 (OR = 2.21, q= 0.043) and rs3013302 (OR = 2.15, q= 0.043). Our
overall findings provide preliminary evidence that NOTCH1 may be implicated in the susceptibility to anxiety and depression
among sexual abuse victims. The study also underscores the potential importance of animal models for future studies on the health
consequences of early-life stress and the mechanisms underlying increased risk for psychiatric disorders.
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INTRODUCTION
Sexual abuse is a potentially devastating event happening at
epidemic rates worldwide. Between 8 and 31% women and 3 and
17% men have experienced sexual abuse during childhood1 or
adulthood.2 The rates reported in Norway are comparable.3 The
stressful nature of sexual abuse is evidenced by a large body of
literature linking sexual abuse to a life-long increased risk to a
wide range of somatic and mental health problems, independent
of the victims’ age at the time of the abuse.4–8 Furthermore, adults
who were sexually abused during childhood display structural and
functional alterations of brain areas and neuroendocrine systems
involved in stress response regulation,9–13 as well as epigenetic
modifications of genes involved in stress regulation.14,15 Such
changes provide potential neurobiological mechanisms under-
lying the association between childhood sexual abuse, or other
types of early-life stress, and the development of disorders later in
life.9,16–20 The understanding of the neurobiology of early-life
stress is still rather limited, however. Stress-induced sustained
elevations in glucocorticoid levels may contribute to both structural
and functional changes in the brain.21,22 Such changes may include
pathological alterations in secretion patterns of the endocrine
system, including melatonin and peptide substances of the pineal
gland23 and glucocorticoids of the hypothalamic–pituitary–adrenal
system.22 Both the pineal gland and the hypothalamic–pituitary–
adrenal system contribute to the general defense responses, with
glucocorticoids postulated to modulate the activity of the pineal
gland.24,25 Moreover, the antistress properties of the pineal gland
have been reported to be mediated by the functional state of the
hippocampus,26 a brain structure especially sensitive to glucocorti-
coids. This brain region has a key role in memory consolidation,
cognition and mood. It is also among the few brain areas capable of
producing new neurons throughout life.27 Sustained elevations in
glucocorticoid levels have been reported to suppress hippocampal
neurogenesis,28 reduce the number of dendritic spines and produce
dendritic atrophy.29 These changes may contribute to the behavioral
impact of early-life stress.22 Correspondingly, clinical neuroimaging
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studies have shown hippocampal atrophy in adolescents and adults
exposed to childhood sexual abuse,11–13 suggesting the possible
involvement of the hippocampus in the pathophysiology triggered
by this adversity.22 Nonetheless, the cellular mechanisms behind
behavioral and molecular changes following sexual abuse are not
yet fully understood.
Although childhood sexual abuse often co-occurs with other
types of adversites,30 it still contributes independently to the risk of
developing anxiety and depression,4,31 two leading causes of global
health burden according to the World Health Organization.32,33
However, not all sexual abuse victims develop anxiety or
depression,34,35 indicating individual differences in susceptibilities
to these symptoms, some of which may be genetically influenced.36,37
The genetic contribution to symptom outcomes among people
victimized by sexual abuse has been sparsely studied, with no
replicable genetic association detected to date.38–40 The lack of
robust associations poses one of the biggest challenges in
contemporary psychiatric genetics as behavioral traits are complex
and loci behind them explain only a small fraction of the
phenotypic variance.41 Although it proves difficult to collect large
samples of sexual abuse victims to achieve the needed power to
detect small effect sizes, one approach to elucidating the genetics
of psychiatric outcomes in this group could be to use animal
models as a candidate gene-generating tool. Clearly, no animal
model of sexual abuse exists. However, childhood sexual abuse can
be broadly characterized as early-life stress, for which several animal
models are available. Early-life stress can be modeled in animals in
the form of compromised maternal care, such as postnatal long
maternal separation (LMS; 3 h each day after birth for 2 weeks). The
separation produces more persistent anxiety- and depression-like
behaviors, as well as concomitant endocrine and neurochemical
changes when LMS offspring are compared with brief maternal
separation (BMS; 10–15 min each day after birth mimicking
naturally occurring separation from the mother), rather than to
non-handled offspring (NH; left undisturbed with their mother).42–44
In the present translational study, we used this well-known
rodent early-life stress model to identify genes revealing
differential expression in hippocampus and/or pineal gland across
early-life stress conditions. Owing to parallels in the stress
pathology, we hypothesized that the human orthologs of the
identified genes would show associations with depression and
anxiety symptomatology in human adults who had experienced
sexual abuse early in life.
MATERIALS AND METHODS
Animal study
This animal study was part of a larger project examining the effects of both
early- and later-life stress conditions on behavior and modulation of brain
gene expression.43,44 All the procedures were performed according to
guidelines of the Norwegian Animal Research Authority (Permit Number:
07/9421-2007025) and conducted in accordance with The European
Convention for the protection of Vertebrate Animals used for Experimental
and other scientific purposes (18 March 1986). The same personnel
handled the animals throughout the study.
Animal breeding and early- and later-life stress. For mating, two females
were housed with one male rat of Wistar strain (NTac:WH, Taconic,
Silkeborg, Denmark). Ten females delivered 120 offspring and the day of
birth was designated postnatal day (PND) 0. The litter size ranged from 4 to
15. Cross-fostering was performed within 24 h after birth to equalize the
litter size to 12 offspring per litter. The mother and litter were housed in
individually ventilated cages (type IV, Tecniplast, Buggugitate, Italy) with an
ambient temperature of 22± 1 °C and air humidity of 52 ± 2%. The light
and dark cycles were 12:12 h with lights gradually increasing/decreasing at
0600 h and 1800 h and fully on/off at 0700 h and 1900 h. Breeding diet
(RM3, Special Diets Services, Witham, Essex, UK) and water were available
ad libitum and replenished once a week. Bedding (Bee Kay Bedding,
Scanbur, Karlslunde, Denmark) was changed once a week, except during
PND 0–14.
The pups were exposed to maternal separation or a non-handling
condition daily from PND 2 to 14. The mother was first moved to a
separate cage with food and water ad libitum. The litter was then moved to
a different room with a cage containing chopped wood bedding and soft
paper. A heating lamp provided a stable temperature (PND 2–7: 32–34 °C,
PND 8–14: 28–30 °C). The mother and her offspring were reunited in the
reverse order. LMS involved 180 min-long separation, whereas BMS lasted
for 10 min, both starting at 0900 h. The offspring in the NH condition were
left undisturbed with their mother (for more details, see ref. 45). Four to
five offspring of the same sex and litter were housed in the same cage at
weaning, PND 22. At PND 55–60, all the animals underwent a surgical
procedure for implantation of transmitter (Physiotel, Data Sciences
International, St. Paul, MN, USA) for continuous wireless recording of sleep
and temperature rhythms, as previously described.43,44 In brief, the animals
were anesthetized with subcutaneous injection of a mixture of fentanyl
0.277 mg kg− 1, fluanizone 8.8 mg kg− 1 and midazolam 2.5 mg kg− 1
(Hypnorm, Janssen, Beerse, Belgium; Dormicum, Roche, Basel, Switzerland;
Midazolam Actavis, Actavis, Parsippany-Troy Hills, NJ, USA) and the
transmitters were placed in subcutaneous pockets in the dorsomedial
lumbar region. The animals were housed individually in individually
ventilated type III cages thereafter and allowed to recover for 14 days
before entering the experiment. All the animals were anesthetized with
pentobarbital and decapitated. The brain was rapidly separated from the
skull and the brain regions (ventral hippocampus and pineal gland)
dissected on an ice-cold glass dish, aliquoted into Eppendorf tubes
(Horsholm, Denmark) and stored at − 80 °C until analysis.
Male rats (n= 60) from each early-life condition were subdivided into
subgroups of later-life stress; a chronic mild stress and a control group,
randomly and balanced between the litters. The 4-week chronic mild stress
paradigm consisted of unpredictable exposure to a variety of mild
stressors, see further details in ref. 45. The control group were given
standard animal care in a separate room.
RNA preparation, labeling and microarray hybridization. The hippocampal
tissue was extracted from 18 NH, 18 BMS and 24 LMS offspring, whereas
the pineal gland tissue was extracted from 12 NH, 9 BMS and 15 LMS
offspring. The tissues were harvested randomly and balanced between the
early-life condition, the later-life condition and between the litters. About
10 mg tissue from each sample was homogenized using the TissueLyser
tissue disruptor (QIAGEN, Hilden, Germany) for 2 × 30 s at 20 000 r.p.m.
Total RNA was extracted using the ABI PRISM 6100 Nucleic Acid Prep
Station (Applied Biosystems, Foster City, CA, USA). The amount and quality
of total RNA was measured using the NanoDrop Spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA) and the Agilent 2100
Bioanalyzer (Santa Clara, CA, USA). All the samples had an RNA integrity
number above 7.5.46 All microarray analyses were performed using the
Illumina Whole Genome Expression Bead Chips (Illumina, San Diego, CA,
USA). Total RNA (500 ng) from hippocampus and pineal gland was reverse
transcribed, amplified and biotin-labeled using the Illumina Total Prep RNA
amplification kit (Ambion, Huntingdon, UK). Biotin-labeled complementary
RNA (750 ng) was hybridized to Illumina RatRef-12 Expression Bead Chips
(Illumina) according to the manufacturer’s instructions. These chips contain
22 523 probes, representing 22 228 rat genes, selected primarily from the
NCBI RefSeq database (release 16). Following hybridization, the Bead Chips
were washed and stained with Streptavidin-Cy3 (Thermo Fisher Scientific,
Waltham, MA, USA). Fluorescent signal detection was performed by the
iScan reader (Illumina) and the resulting images were processed by
Genome Studio Software v2009.1 (Illumina). The signal intensities were
imported into the J-Express 2012 software (Molmine, Bergen, Norway),47
where inter-array quantile normalization and base 2 logarithmic transfor-
mation were performed to minimize the technical artifacts (for example,
RNA extraction, labeling and hybridization) and to obtain a normal
distribution, respectively. The investigators were blinded to the group
allocation during the analyses.
Analysis of gene expression. Global trends in the data were examined by
correspondence analysis.48 In the correspondence analysis plot, the
microarray data for genes and samples are projected onto a two-
dimensional plane defined by the first and second principal components.
The samples that are close together in the plot have a more similar global
gene expression than those that are further apart.
Identification of microarray probes that differed significantly in
expression level (that is, hybridization signal intensity) in the hippocampus
and/or pineal gland between the different early-life conditions was carried
out by significance analysis of microarrays (SAM),49 comparing signal
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intensities of all probes across early-life conditions within a specific brain
region. Separate SAM analyses were thus performed within the
hippocampus and pineal gland, respectively; LMS vs NH, LMS vs BMS
and BMS vs NH. To minimize the number of false positives, the SAM
analysis threshold was set to a q-value of 0 (see ref. 50).
To identify genes that may be affected as a result of adverse life events,
we used a combination of statistical significance of differential expression,
visual inspection of gene expression profile across individual samples and
potential involvement of candidate genes in neurological development
and/or disorders. More specifically, the list of differentially expressed genes
resulting from the SAM analysis was subjected to visual inspection of
individual gene expression profiles, aiming to eliminate false positive
findings that may have arisen as a result of low signal levels and technical
artefacts. This trimmed list was subsequently screened for genes with
known or suggested involvement in neurological development and/or
disorders, by manual inspection of gene annotation such as gene ontology
and pathways, as well as literature searches.
Human genetic association study
Participants. Sexually abused individuals were recruited from two
different sources: (1) support centers for sexual abuse victims (2) a
representative sample of the Norwegian population aged 18–80 years.3,51
The recruitment of participants was conducted in line with ethical
principles specified in the Declaration of Helsinki, including the ensuring
of informed consent to participate in the study.
All respondents from the sexual abuse support centers were classified as
sexually abused based on self-reports. From the general population of
Norway aged 18–80 years, a random sample of 1450 men and women
were invited to participate in a survey assessing unwanted sexual
experiences, of which 703 (48.7%) responded. Subsequently, a saliva
collection kit was sent to those who agreed to provide a saliva sample
(n=306). Unwanted sexual experiences were classified according to the
sexual abuse categorization provided by the Norwegian criminal code,
which differentiates between unwanted sexual behaviors (for example,
sexual exposure or other sexual behaviors not involving physical contact),
unwanted sexual acts (for example, sexual touching and fondling) and
unwanted intercourse (for example, penetration of fingers/penis/object
into victims anus/vagina/mouth). To reduce the likelihood of falsely
classifying people as sexually abused, only those reporting unwanted
sexual intercourse or acts were included in the study (see Supplementary
Table 1 for an overview of the items used to assess these experiences). In
the representative population study, a check list assessed the respondents’
exposure to multiple types of unwanted sexual acts and intercourse. Their
age the first time these incidents took place was assessed separately for
each item. In the sample of support center users, age at first abusive
incident was assessed using an open-ended question.
In total, 710 recruited individuals (537 from the support centers and 173
from the general population) were classified as sexually abused (aged 17 to
73 years; Mean = 41.6, s.d. = 13.1, 93.1% female). Four hundred and three
participants provided DNA samples (306 from the support centers and 97
from the general population; see Supplementary Figure 3 for a flowchart
displaying this selection process). Mean age at the first abusive incident
was 6.5 years (s.d. = 3.9 years) in the sample of support center users, and
14.8 years (s.d. = 4.1 years) for sexual abuse involving intercourse in the
representative population sample.
Each participant provided a DNA sample collected with the OG-100
saliva kit (Oragene, DNA Genotek, Ottawa, ON, Canada) and a standard
Oragene protocol was applied to perform DNA extraction. The study was
approved by the Regional Committee for Medical and Health Research
Ethics of Western Norway (approval number 264.08).
Measures of anxiety and depression symptoms. Symptoms of anxiety and
depression were assessed using the Hospital Anxiety and Depression Scale
(HADS).52 Cronbach’s α for the total scale in the current sample was 0.91.
To categorize symptoms of anxiety and depression from the HADS, a
person-driven approach (fuzzy clustering) was applied.53 Fuzzy clustering
was performed in the R software, using FANNY algorithm.54 Each individual
was assigned to one of the following clusters: ‘No symptoms’ (scoring low
on both anxiety and depression scales), ‘Anxiety only’ (scoring high on
anxiety scale and low on depression scale), ‘Depression only’ (scoring high
on depression scale and low on anxiety scale) and ‘Comorbid symptoms’
(scoring high on both anxiety and depression scales).
Apart from sexual abuse and anxiety and depression symptoms
measures, the participants were also assessed for their current perception
of social support using the Multidimensional Scale of Perceived Social
Support questionnaire,55 which addresses perceived social support from
friends, family and significant others. Cronbach’s α for the scale was 0.93.
SNP selection and genotyping. SNPs (single-nucleotide changes in the
DNA sequence with a minor allele frequency of at least 1%) of the
candidate genes identified in the animal study were tagged in Haploview
software;56 using HapMap CEU genotype data (release 28). The tagging
was based on the SNPs passing the following criteria: minor allele
frequency above 5%, no Mendelian errors, Hardy–Weinberg P-value below
0.01 and genotyping rate above 95%. Pairwise tagging algorithm was
performed with r2 threshold above 0.8.
Genotyping of tagging SNPs was accomplished by MassArray iPlex
(Sequenom, San Diego, CA, USA) system at CIGENE center for genotyping
(University of Life Sciences, Ås, Norway). Genotyping quality control was
implemented in PLINK and consisted of Hardy–Weinberg test (Po0.009)
and genotyping rate above 95%.57 In addition, the variants’ minor allele
frequencies observed in our sample were compared with those reported
for CEU population in the 1000 Genomes Project (pilot one).
Statistical analyses
Before the assessment of genetic association, exploratory regression
analyses were performed to determine possible confounders measured in
this study. Thus, the effect of gender, age, recruitment source and
perceived social support on the measured anxiety and depression
symptoms was calculated. Genetic association between tagging SNPs
and the anxiety and depression symptoms measure was then tested,
adjusting for confounders revealing significant effects in the exploratory
step. All modeling was done in the form of multinominal logistic
regression. Correction for multiple testing was achieved by false discovery
rate.58 The false discovery rate q-value below 0.05 was considered
significant. All analyses were conducted in the R software.
The functional potential of polymorphisms revealing significant
associations before false discovery rate correction was examined in silico
in relation to the brain tissue as well as hippocampus specifically using
HaploReg software, version 4.59 Given that we examined tagging SNPs, we
extended our HaploReg evaluation to all SNPs in linkage disequilibrium
with the examined ones (r2 40.8).
Exploratory analysis revealed statistically significant effects of age,
perceived social support and recruitment source (representative popula-
tion vs support centers) on the anxiety and depression outcome measure.
Subsequently, age, perceived social support and sample source were
included as covariates in the final regression model testing for genetic
association. We used the ‘No symptoms’ group as the reference group.
RESULTS
Animal study
Gene expression in the hippocampus and pineal gland of LMS, BMS
and NH offspring. Global gene expression in the hippocampus
and pineal gland of rats subjected to the three different early-life
conditions was first studied by correspondence analysis. On the
global level, within each brain region, no systematic differences in
the brain gene expression could be observed between any of the
different early-life conditions (Supplementary Figures 1 and 2).
Gene level differential gene expression after early-life stress was
examined by SAM. Very few genes displayed significant differ-
ential expression between the different early-life stress conditions.
Within the hippocampus, seven, three and two genes were
significantly differentially expressed between LMS and NH, LMS
and BMS, as well as BMS and NH offspring, respectively (Table 1).
Within the pineal gland, seven genes were significantly differen-
tially expressed between LMS and NH offspring, and two genes
between LMS and BMS offspring (Table 1). A few genes showed
significant differences across several conditions, such as Plk5 being
upregulated in the pineal gland of both LMS and BMS offspring
compared with NH offspring, and Zfp644 being downregulated in
LMS offspring compared with NH offspring in both hippocampus
and pineal gland (see Figure 1 and Table 1). Several genes showed
similar tendencies, although not significantly, in additional
comparisons (see Supplementary Table 2). Furthermore, as
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illustrated in Figure 1, among the BMS brain samples, many of the
differentially expressed genes displayed intermediary expression
levels, falling somewhat in the middle between those observed in
the brain samples of NH and LMS offspring (also see
Supplementary Table 2).
By visual inspection of individual gene expression profiles and
gene annotation, we selected four genes showing robust
differential expression among animals subjected to different
early-life conditions, as well as having potential relevance for
neurological development or disorders for further analysis in the
human association study: Notch1, Gabrr1, Plk5 and Zfp644
(Table 1).
Human genetic association study
Anxiety and depression symptoms. Fuzzy clustering of HADS
measures identified three main clusters (Table 2). Cluster 1 was
characterized by low scores on both the anxiety and depression
subscales, and was thus labeled as ‘No symptoms’ group. Cluster 2
revealed high scoring on the anxiety subscale and low scoring on
the depression subscale, and was labeled as ‘Anxiety only’ group.
Cluster 3 was labeled as ‘Comorbid symptoms’ group, based on
scoring high on both the anxiety and depression subscales. A
‘depression only’ cluster was not observed.
SNP selection and genotyping. We identified the four human
orthologs of the selected candidate genes from the rat study:
NOTCH1, PLK5, ZNF644 and GABRR1. Overall, 47 SNPs were
determined as tag SNPs for them. One SNP failed the multiplex
design and two SNPs failed the Hardy–Weinberg test, leaving 44
SNPs available for the analyses. In total, 361 participants (269 from
the support centers for sexual abuse survivors and 92 from the
general population) were successfully genotyped (Supplementary
Figure 3).
Associations of SNPs with anxiety and depression symptoms. Sig-
nificant associations were noted for four SNPs in the GABRR1 gene
and one SNP in the NOTCH1 gene when comparing the ‘No
symptoms’ to the ‘Anxiety only’ group. However, none of these
remained significant after correction for multiple testing
(Table 3a). When comparing ‘No symptoms’ group to the
‘Comorbid symptoms’ group, significant effects were found for
four SNPs in the NOTCH1 gene (Table 3b). Two of these SNPs,
rs3013302 and rs11145770, survived the correction for multiple
testing. No significant effects were found in ZNF644 and PLK5
genes. The association results of all the examined SNPs are
summarized in Supplementary Table 3.
HaploReg analyses showed regulatory potential for SNPs within
the NOTCH1 gene, including those in high linkage disequilibrium
with rs3013302 and rs11145770, with promoter and enhancer
activity in fetal brain and several brain regions, including the
hippocampus. In addition, these SNPs also revealed eQTL
(expression quantitative trait locus) activity in relation to the
following genes: NALT1 (RP11-611D20.2 transcript), INPP5E, CARD9,
PMPCA, SNAPC4 and LOC286254. In the GABRR1 gene, only one
SNP—rs453503—displayed promoter activity in the brain, but not
in the hippocampus. Similarly to NOTCH1, variants in GABRR1 also
possessed eQTL function as reported in arterial tissue.60 All
HaploReg results are summarized in Supplementary Table 4.
Table 1. Genes with significant (q= 0) differential expression in pineal gland and/or hippocampus between animals subjected to LMS, BMS and NH
controls
Probe ID Gene ID Gene symbol Gene name Fold differencea
Pineal gland
BMS vs NH
ILMN_1375780 303439 Maf Monocyte to macrophage differentiation-associated 1.23
ILMN_1352420 314627 Plk5 Polo-like kinase 5 1.30
LMS vs NH
ILMN_1369757 305127 Zfp644 Zinc finger protein 644 − 1.24
ILMN_1354493 25338 Ninj1 Ninjurin 1 − 1.19
ILMN_1368424 303702 Engase Endo-beta-N-acetylglucosaminidase − 1.15
ILMN_1373511 116745 Kcnh6 Potassium voltage-gated channel, subfamily H (eag-related), member 6 1.27
ILMN_1352420 314627 Plk5 Polo-like kinase 5 1.40
ILMN_1376353 311872 Zbtb43 Zinc finger and BTB domain containing 43 1.43
ILMN_1372167 313644 Rap1ga1 RAP1, GTPase activating protein 1 2.00
LMS vs BMS
ILMN_1356838 308060 Ccdc127 Coiled-coil domain containing 127 1.25
ILMN_1373838 29694 Gabrr1 Gamma-aminobutyric acid (GABA) receptor, rho 1 1.32
ILMN_1349159 498433 Psme4 Proteasome activator subunit 4 − 1.44
Hippocampus
LMS vs NH
ILMN_1357880 64347 Sncg Synuclein, gamma (breast cancer-specific protein 1) − 1.60
ILMN_1373010 362484 Plekhf2 Pleckstrin homology domain containing, family F (with FYVE domain) member 2 − 1.39
ILMN_1373132 362134 Mmadhc Methylmalonic aciduria and homocystinuria, cblD type − 1.41
ILMN_1373950 362685 Gpatch11 G patch domain containing 11 − 1.30
ILMN_1369757 305127 Zfp644 Zinc finger protein 644 − 1.27
ILMN_1370841 309391 Cox15 COX15 homolog, cytochrome c oxidase assembly protein 1.09
ILMN_1359640 25496 Notch1 Notch gene homolog 1 1.16
LMS vs BMS
ILMN_1356902 29131 Cartpt CART prepropeptide − 1.24
ILMN_1650165 295264 Mllt11 Myeloid/lymphoid or mixed-lineage leukemia; translocated to 11 − 1.32
Abbreviations: BMS, brief maternal separation; LMS, long maternal separation; NH, non-handled. aPositive or negative fold difference indicates up- or
downregulation of probe in first vs second group, for example, in BMS vs NH. Group comparison is indicated in italics. Genes selected for human genetic
association study are highlighted in bold.
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DISCUSSION
In this translational study, we aimed to examine the genetic
contribution to anxiety and depression symptoms among sexual
abuse victims using an animal experimental study as a candidate
gene-generating tool. Among a list of 20 differentially expressed
genes in the brains of rats exposed to different early-life
conditions, we selected four candidate genes based on their level
and robustness of differential gene expression, as well as potential
relevance for neural development or disorders. These candidate
genes were then tested for their association with anxiety and
depression symptoms in a sample of human adults who had
experienced sexual abuse early in life.
The main finding of the present study was the implication of
NOTCH1 as a candidate gene for the pathomechanisms following
early-life stress that may be relevant for the development of
anxiety and depression in humans who experienced sexual abuse.
We observed increased expression of this gene in the hippocam-
pus of rats exposed to long maternal separations early in life
compared with those who were left undisturbed with their mother
(Figure 1, Table 1). NOTCH1 also showed associations with anxiety
and depression symptoms in our sample of sexual abuse victims.
Specifically, minor alleles of two NOTCH1 tag SNPs—rs3013302
and rs11145770—were associated with higher likelihood of
displaying comorbid anxiety and depression symptoms compared
with not displaying these symptoms in a sample of sexual abuse
victims (Table 3b).
The NOTCH1 gene encodes the NOTCH1 receptor, a member of
the Notch transmembrane protein family.61 Its expression is
documented in several areas of the adult brain, including the
hippocampus in both humans and mice.62,63 Functionally, the
Notch signaling pathway influences cell fate decisions in many
developmental processes,61 and the Notch1 gene has been
reported to have important regulatory roles in hippocampal
neurogenesis in animal studies.64,65 Importantly, expression of
NOTCH1 has been found to be influenced by glucocorticoids,66,67
hormones elevated in response to stress. Moreover, cross-talk
between glucocorticoids and the Notch signaling pathway has
been demonstrated in human hippocampal cells68 as well as in
Figure 1. Box plots illustrating relative expression levels (quantile normalized, log2-transformed signal intensities) of Notch1, Zfp644, Gabrr1
and Plk5 in hippocampus (a) and/or pineal gland (b) of rat offspring experiencing long (LMS), brief (BMS) or no (NH) maternal separation. The
box plots indicate the median of the distribution (thick black line), 75th percentile (upper edge of box), 25th percentile (lower edge of box),
95th percentile (upper edge of vertical line), 5th percentile (lower edge of vertical line) and the outlier points (above and below vertical lines).
Table 2. Means and standard deviations of HADS subscale scores in










HADS-anxiety 3.29 (1.63) 8.43 (2.14 ) 13.13 (2.97 )
HADS-depression 1.56 (1.72) 3.48 (2.09 ) 8.82 (3.27)
Abbreviation: HADS, Hospital Anxiety and Depression Scale. Interpretation
of HADS scores: ⩾ 8: possible, and ⩾11: probable clinically significant
anxiety/depression.52
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other cell types.66,67,69 It has also become increasingly evident that
newly produced hippocampal neurons may have a direct role in
regulating the stress response.70,71 In addition, the Notch signaling
pathway has been implicated in the development of depression
symptoms in a previous study.72 Moreover, as our comparison
group consisted of sexual abuse victims who did not report
symptoms of anxiety and depression, NOTCH1 may also be
postulated to have a role in the neurobiology of resilience to these
symptoms among sexual abuse victims.
Stress-induced changes in hippocampal neurogenesis have
long been believed to have a key role in the etiology of
depression and anxiety.73,74 A number of studies report that
stress is both a suppressor of hippocampal neurogenesis and a
significant precipitating factor in the development of depression
and anxiety.73–76 In addition, studies suggest that hippocampal
neurogenesis may mediate the effect of antidepressants.77,78
These findings correspond with neuroimaging studies showing
hippocampal atrophy observed in people who have experienced
stressful events, including sexual abuse,10–13,79 as well as in people
with depression and anxiety disorders.80–82 In addition, hippo-
campal neurogenesis has been found to mediate the association
between early-life stress and depression longitudinally.79 Thus, our
observation of Notch1 expression change following exposure to
early-life stress in rats as well as the association of NOTCH1 tag
SNPs with anxiety and depression symptoms in victims of sexual
abuse is in line with the neurogenesis hypothesis of affective and
anxiety disorders73–76,83,84
Both tag SNPs of NOTCH1 gene revealing associations with
anxiety and depression symptoms in this study, as well as variants
in high linkage disequilibrium with them, showed regulatory
potential by displaying both enhancer and promoter properties in
brain tissue, including hippocampus (Supplementary Table 4).
Moreover, these SNPs also exhibit eQTL activity related to long
noncoding RNA genes (LOC286254, NALT1) and genes involved in
signal transduction (INPP5E, CARD9), mitochondrial processing
(PMPCA) and nuclear RNA activation (SNPC4). It has recently been
observed that SNPs previously associated with neurological and
psychiatric conditions may be highly concentrated in the regions
of long noncoding RNA genes.85 Furthermore, the apparent lack of
exonic polymorphisms among genome-wide significant associa-
tions of psychiatric disorders may suggest that alterations in gene
expression rather than protein structure could be the molecular
mechanism leading to these conditions.86,87 Such eQTL effect of
SNPs in NOTCH1 gene may also indicate that a pathway other than
NOTCH1 could underlie the current findings.
Apart from Notch1, we also noted significant changes in gene
expression of Gabbr1, Plk5 and Zfp644 in the rodent model
(Table 1). Similar to NOTCH1, the orthologs of these genes have
previously been implicated in both neurogenesis and stress.88–91
However, only GABRR1 revealed nominal association with anxiety
and depression symptoms in our sample of sexually abused
individuals (Table 3a).
GABRR1 gene encodes the ionotropic GABAA receptor of
gamma aminobutyric acid (GABA), the main inhibitory neuro-
transmitter in the central nervous system.92 The activation of
GABAA has been reported to inhibit neuronal activity,
93 making
this receptor the target for a vast number of psychoactive drugs,
including anxiolytics (anti-anxiety) and antidepressants.94,95
Indeed, considerable evidence from a number of studies suggests
that GABAA has an important role in the pathogenesis of both
anxiety and depression.96 It has also been shown that conflict
stress can alter the expression of GABA receptor subunits in
rodents, which, in turn, may lead to dramatic changes in its
function.97 Moreover, GABAergic mechanisms have been pro-
posed as possible mediators of the interplay between aversive
memories and stress endocrinology.96
The expression of Plk5 and Zfp644 was altered in our rodent
model of early-life stress (Table 1). Plk5 encodes polo-like kinase 5,
while Zfp644 encodes zinc finger protein 644. Plk5 is mostly
expressed in the brain, where it is involved in the regulation of
neuritic processes.88 Paralogs of this gene have been implicated in
stress response pathways.98 Zfp644 is a ubiquitously expressed
transcription factor, whose function has not yet been substantially
characterized. So far, it has been implicated in eye development.99
Although the tag SNPs in orthologs of these genes did not reveal
associations with anxiety and depression symptoms in the current
Table 3b. Association results of the nominally significant SNPs in the human study
Gene SNP Chr. Position (GRCh38) ‘No symptoms’ vs ‘Comorbid symptoms’
OR (95% CI) P-value q-value
NOTCH1 rs11145770 9 136532614 2.21 (1.35–3.61) 0.002 0.043a
NOTCH1 rs3013302 9 136537422 2.15 (1.32–3.49) 0.002 0.043a
NOTCH1 rs13301342 9 136499893 0.36 (0.16–0.77) 0.009 0.097
NOTCH1 rs13290979 9 136531182 1.92 (1.18–3.15) 0.009 0.097
Abbreviations: 95% CI, 95% confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism. aFalse discovery rate q-value o0.05. The full table of
results is presented in Supplementary Table 3.
Table 3a. Association results of the nominally significant SNPs in the human study
Gene SNP Chr. Position (GRCh38) ‘No symptoms’ vs ‘Anxiety only’
OR (95% CI) P-value q-value
GABRR1 rs9342185 6 89204419 0.44 (0.25–0.78) 0.005 0.215
GABRR1 rs4707529 6 89208843 0.47 (0.26–0.86) 0.015 0.241
GABRR1 rs7758893 6 89206922 0.53 (0.30–0.92) 0.025 0.241
GABRR1 rs453503 6 89190880 0.52 (0.29–0.93) 0.028 0.241
NOTCH1 rs11145770 9 136532614 1.79 (1.10–2.89) 0.018 0.241
Abbreviations: 95% CI, 95% confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism. False discovery rate q-value o0.05. The full table of
results is presented in Supplementary Table 3.
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sample of sexually abused individuals, their altered expression
following early-life stress in rats indicates their relevance as
interesting candidate genes for further exploration of health
outcomes following stressful events, especially as molecular
characterization of these genes is sparse.
Some limitations of the present studies should be noted. The
small number of litters may explain the lack of more statistical
power in terms of detecting more candidate genes. Also, the
animal study did not examine active maternal behavior (licking
and grooming activity) during the postnatal period. Active
maternal care is important for normal neuronal development.
Adding information of maternal behavior could have provided
important indications as to whether differences in gene expres-
sion observed in adult LMS and NH offspring may be associated
with low/high levels of maternal licking and grooming. Given our
modest sample size of sexually abused individuals, one major
constraint of an association study is its modest power that may
have prevented us from detecting signals of small effects sizes.
The mood phenotypes in our sample of sexually abused
individuals were derived from self-reports, whose clinical validity
may be considered uncertain. However, HADS scores have been
shown to be a good reflection of clinical anxiety and
depression.100 Given the lack of information on ethnicity in the
present study, we cannot rule out potential biases introduced by
population stratification in our genetic association findings.
However, such bias is unlikely as the minor allele frequencies of
examined SNPs in our sample did not deviate significantly from
the Northern European sample from Utah (CEU) of the 1000
Genomes Project, suggesting that our Norwegian sample reflects a
European population overall. It should also be noted that we
examined tag SNPs only, allowing us to capture significant loci
rather than specific polymorphisms. Finally, our comparison group
was shared between analyses of anxiety only and comorbid
conditions. This may have biased our false discovery rate
correction. Thus, our findings implicating NOTCH1 gene in
susceptibility to anxiety and depression among sexual abuse
victims should be further examined in larger samples, using
clinically validated mood phenotypes.
In conclusion, our results revealed a number of candidate genes
with differential expression in brain regions following early-life
stress in rats (Table 1). Furthermore, our results implicate the
NOTCH1 system in the susceptibility to comorbid anxiety and
depression symptoms in a sample of sexually abused individuals.
Although further investigations clearly are needed to validate and
elucidate the exact role of the Notch signaling pathway in the
pathology of stressful events, the associations observed in our
study of sexually abused individuals together with the differential
expression pattern in rats support the notion that NOTCH1 could
be involved in the liability and resilience to such pathology.
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